Shanghai Fosun Pharmaceutical Group Co Ltd
Fosun Pharma's GHG Emissions Data Preview
In 2024, Fosun Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Fosun Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Fosun Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Fosun Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Fosun Pharma's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Fosun Pharma amounted to 837,660 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Fosun Pharma decreased by 5.74%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Fosun Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Fosun Pharma's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Fosun Pharma were 184,016 metric tons of CO₂ equivalent (tCO₂e). a
Has Fosun Pharma reduced its Scope 1 emissions over time?
Since 2018, Fosun Pharma's Scope 1 emissions have decreased by 53.54%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2023), Fosun Pharma's Scope 1 emissions decreased by 12.71%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Fosun Pharma's Scope 2 emissions?
In 2024, Fosun Pharma reported Scope 2 greenhouse gas (GHG) emissions of 653,644 tCO₂e without specifying the calculation method. a
Has Fosun Pharma reduced its Scope 2 emissions over time?
Since 2018, Fosun Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 67.92%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2023), Fosun Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Fosun Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Fosun Pharma use for Scope 2 reporting?
In 2024, Fosun Pharma reported its Scope 2 emissions using an unspecified methodology. a
Fosun Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Fosun Pharma's Value Chain Emissions
In 2024, Fosun Pharma reported 91,775 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Fosun Pharma includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Fosun Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Fosun Pharma's Scope 3 emissions?
In 2024, Fosun Pharma reported total Scope 3 emissions of 91,775 metric tons of CO₂ equivalent (tCO₂e). a
Has Fosun Pharma reduced its Scope 3 emissions over time?
Since 2018, Fosun Pharma's Scope 3 emissions have increased by 8,690.71%, reflecting a rising long-term trend in Scope 3 emissions over time. a
Compared to the previous year (2023), Fosun Pharma's Scope 3 emissions increased by 27.16%, suggesting that the company faced challenges in reducing emissions across its value chain. a
Insights into Fosun Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Fosun Pharma reported Scope 1 greenhouse gas (GHG) emissions of 184,016 tCO₂e and total revenues of USD 5,627 millions. This translates into an emissions intensity of 32.7 tCO₂e per millions USD. a
Fosun Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Fosun Pharma's GHG emissions intensity compare to its peers?
In 2024, Fosun Pharma reported a Scope 1 emissions intensity of 32.7 tCO₂e per millions USD. Compared to the peer group median of 23.6 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Fosun Pharma rank on GHG emissions intensity within its industry?
In 2024, Fosun Pharma ranked 18 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Fosun Pharma is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into Fosun Pharma's Total Carbon Footprint
In 2024, Fosun Pharma reported a total carbon footprint of 929,435 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 3.27% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output. a
The largest contributor to Fosun Pharma's total carbon footprint was Scope 2 emissions, accounting for 70.33% of the company's total carbon footprint, followed by Scope 1 emissions at 19.8%. a